Skip to main content

Breast MRI QC and ACR Accreditation

By Troy Zhou, PhD, DABR, DABSNM
March 18, 2025 16 min read

Introduction

Breast MRI accreditation rests on two linked image streams: phantom quality control that proves the scanner is physically stable, and clinical images that prove the protocol actually resolves and enhances small lesions. A defensible breast MRI program connects those two streams through a documented quality control (QC) schedule and an annual medical physicist evaluation, so that a weak clinical submission can be traced back to a measurable scanner parameter rather than guessed at.

Breast MRI is one of the most technically demanding examinations in diagnostic imaging. It asks a scanner to deliver thin slices, high in-plane resolution, uniform fat suppression, and reproducible dynamic contrast enhancement across both breasts simultaneously, often at 3 T, using a dedicated breast coil. Any one of those requirements can fail quietly, and a failure that is invisible on a routine brain scan can hide or mimic a small enhancing cancer. 1, 7

That is why the American College of Radiology (ACR) Breast MRI Accreditation Program evaluates both phantom and clinical images, and why the program depends on a qualified medical physicist performing an annual equipment performance evaluation. 1, 2, 3 This guide explains what the program reviews, how the underlying physics of signal-to-noise ratio (SNR), image uniformity, and fat suppression drives the QC tests, and how DRPS supports facilities through MRI physics testing and accreditation support across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

What is breast MRI accreditation?

Breast MRI accreditation is a structured review in which a facility submits phantom images, clinical images, and documentation so that an external body can confirm the program produces diagnostic-quality breast MRI. The ACR Breast MRI Accreditation Program is the most widely used pathway in the United States, and it is distinct from, though related to, the general ACR MRI Accreditation Program. 1

A facility pursuing or maintaining accreditation must demonstrate three things:

  • The scanner meets quantitative phantom criteria (geometric accuracy, uniformity, resolution, and stability).
  • The clinical breast protocol meets specific acquisition requirements (slice thickness, in-plane resolution, fat suppression, and a dynamic contrast-enhanced series).
  • A qualified medical physicist or MRI scientist performs an annual equipment performance evaluation and documents it. 2, 3

These requirements connect directly to the services a facility may need when preparing: MRI physics testing, accreditation support, and ongoing medical physicist consulting. For a broader view of how accreditation requirements are structured across modalities, see ACR Accreditation Physics Requirements.

The two image streams

The program's logic is that phantom images and clinical images answer different questions:

  • Phantom images answer: Is the scanner physically performing to specification? They are acquired under controlled, repeatable conditions so that small drifts are measurable over time.
  • Clinical images answer: Does the protocol, as applied to real patients, produce diagnostic breast MRI? They test the full chain, including the dedicated breast coil, fat suppression, and contrast timing. 1

A program that passes phantom QC but submits weak clinical images usually has a protocol or coil problem, not a hardware stability problem. A program that fails phantom QC has a measurable hardware or calibration issue that will eventually show up clinically. Keeping both streams documented is what lets a medical physicist localize the cause of a deficiency.

Key Technical Principles

Signal-to-noise ratio: the foundation metric

SNR is the single most important quantitative indicator of MRI system health, and most other image-quality problems eventually show up as an SNR change. The NEMA two-identical-image subtraction method is the most common QC approach: acquire two identical phantom images, measure the mean signal in a large region of interest (ROI), subtract the two images, and estimate noise from the standard deviation of the difference image. 5

The appears because subtracting two independent images with equal noise variance yields a difference image with variance , so the single-image noise is . As a worked example, suppose the phantom ROI mean signal is (arbitrary units) and the difference-image standard deviation over the same ROI is :

The absolute number is less important than its stability. A breast coil element that degrades will drop channel SNR, and tracking SNR weekly or at each physicist evaluation catches that degradation before it reaches clinical images. 5, 7

Percent image uniformity

Percent image uniformity (PIU) quantifies how flat the signal is across a uniform phantom, and it is defined in the ACR MRI QC framework from the maximum and minimum mean signal in small ROIs placed within a large uniform region: 2, 6

For example, if and inside the uniform region:

The ACR action limit for PIU is field-strength dependent, with a higher threshold permitted for systems below 3 T and a somewhat lower threshold for 3 T systems; the current ACR MRI Quality Control Manual gives the exact values a facility must meet. 2 Poor uniformity in a breast exam is clinically dangerous because it can imitate asymmetric enhancement between the two breasts.

Ghosting, geometric accuracy, slice thickness, and resolution

The ACR phantom QC battery also includes several tests whose action limits are specified in the ACR MRI Quality Control Manual. Percent signal ghosting (PSG) is computed from ROIs placed outside the phantom along the phase- and frequency-encode directions relative to a signal ROI:

The table below summarizes the core phantom tests, the physical quantity each probes, and the general QC intent. Exact numeric action limits should always be read from the current ACR MRI Quality Control Manual rather than memorized. 2

Phantom test Physical quantity Why it matters for breast MRI Typical QC intent (read exact limits from the ACR manual)
Geometric accuracy Spatial scaling / gradient calibration Lesion size and localization accuracy Measured lengths within about ±2 mm of true
High-contrast spatial resolution In-plane resolving power Detection of small enhancing foci Resolve the smallest specified hole array (about 1.0 mm)
Slice thickness accuracy Slice profile Partial-volume dilution of small lesions Near nominal (for example, 5.0 mm within a small tolerance)
Percent image uniformity RF/B1 and receive uniformity Avoids mimicking asymmetric enhancement Above a field-strength-dependent threshold
Percent signal ghosting Motion/stability artifact level Keeps ghosts from simulating lesions Below a small specified fraction
Low-contrast detectability Contrast resolution Conspicuity of subtle enhancement At least a specified number of visible spokes

Fat suppression physics

Because breast tissue is largely adipose, uniform fat suppression is not a cosmetic preference but a core diagnostic requirement. Fat and water protons precess at slightly different frequencies; at 1.5 T the chemical-shift separation is about 220 Hz, and it scales with field strength, so at 3 T it is roughly 440 Hz. Fat-suppression techniques exploit this separation (spectral fat saturation), the difference in T1 (inversion recovery such as STIR), or both (hybrid methods). 7, 8

Uneven static field (B0) or transmit field (B1) across the two breasts degrades spectral fat saturation and produces asymmetric suppression, which is why shimming quality and coil positioning are part of breast MRI QC in practice. A medical physicist evaluating a breast MRI program will inspect fat-suppression uniformity on clinical images and relate any asymmetry back to measured B0 homogeneity and coil performance.

Clinical Impact

What the clinical images have to prove

Breast MRI is used for high-risk screening, extent-of-disease evaluation, problem solving, and treatment-response assessment. In all of these, the diagnostic engine is the dynamic contrast-enhanced (DCE) series: a pre-contrast T1-weighted acquisition followed by several post-contrast acquisitions that capture the wash-in and wash-out kinetics of enhancing tissue. 4, 8

For accreditation, the clinical protocol generally must demonstrate:

  • Thin slices: 3 mm or less with no interslice gap, to limit partial-volume dilution of small lesions.
  • High in-plane resolution: pixel dimensions on the order of 1 mm or less.
  • Bilateral coverage: both breasts imaged together for symmetric comparison.
  • Effective fat suppression (or a subtraction technique) so enhancing lesions are conspicuous.
  • A proper dynamic series: one pre-contrast plus multiple post-contrast T1-weighted acquisitions, with the early post-contrast phase captured promptly after injection so that wash-in kinetics are preserved. 1, 4

The kinetics matter clinically: malignant lesions often show rapid early enhancement followed by washout, and the ability to characterize that curve depends directly on adequate temporal resolution without sacrificing the SNR needed for spatial detail. Research on DCE-MRI reconstruction has shown that accurate kinetic parameters require the acquisition to maintain sufficient SNR; in one phantom and modeling study, high SNR (on the order of 30 dB or better) was needed to keep lesion-kinetic errors small at accelerated temporal resolution. 7 Pharmacokinetic modeling and conventional kinetic-curve analysis both improve lesion characterization when the underlying image quality supports them, and the BI-RADS MRI lexicon standardizes how those kinetic curves and morphologic features are reported. 8, 9

When QC failures become clinical failures

  • A dropped coil channel reduces SNR on one side, producing apparent asymmetry.
  • Poor B0 shim degrades fat suppression, leaving bright fat that hides or imitates enhancement.
  • Slice-thickness drift dilutes small lesions by partial-volume averaging.
  • Geometric distortion misstates lesion size, which matters for surgical planning.

Each of these is measurable in phantom QC or the physicist evaluation before it harms a patient, which is the entire point of a documented program. For the general artifact background, see MRI image artifacts and QC and MRI SNR and RF coil QC.

Practical Optimization Tips

1. Separate routine QC from the annual evaluation

Technologists run weekly phantom QC and a daily or weekly visual checklist under a written program. The qualified medical physicist performs the comprehensive annual evaluation and reviews the technologist QC trend. Keep the two logs linked so a physicist can see drift between visits. 2, 3

2. Track trends, not just pass/fail

A parameter that is still within its action limit but steadily declining (for example, falling SNR over three months) is an early warning. Plotting QC values over time is more useful than a single pass/fail stamp.

3. Treat fat suppression as a first-class metric

Inspect fat-suppression uniformity on every clinical breast series, not just on the accreditation submission. Asymmetric suppression should trigger a B0 shim and coil-positioning check.

4. Protect the dynamic series timing

Do not let protocol "optimization" quietly lengthen the early post-contrast phase. The wash-in window is diagnostic; stretching it to gain resolution can destroy the kinetic information. Balance temporal resolution against SNR deliberately. 7

5. Re-evaluate after service

Any gradient, RF, coil, or software change that could affect image quality should trigger a focused physicist re-evaluation, not wait for the next annual visit. 3

Common pitfalls to avoid

  • Assuming MQSA covers breast MRI. It does not; MQSA is mammography-only.
  • Using a head-coil QC program for a breast program. The dedicated breast coil has its own SNR and uniformity behavior.
  • Ignoring 3 T uniformity. Higher field strength makes fat suppression and uniformity harder, not easier.
  • Submitting clinical images without checking fat suppression. This is a frequent deficiency.
  • Letting technologist QC and the physicist evaluation live in separate binders so no one sees the trend.

Regulatory Considerations

Breast MRI quality is governed by accreditation and technical standards, not by the federal mammography statute. MQSA applies to mammography; breast MRI, as a non-ionizing modality, is covered by the ACR Breast MRI Accreditation Program and by facility accreditation bodies rather than by the federal mammography statute. 10 A facility should document its program against the following frameworks: 1, 2, 3, 4, 11

  • ACR Breast MRI Accreditation Program — defines the phantom and clinical image submissions, personnel qualifications, and QC expectations a breast MRI facility must meet. 1
  • ACR MRI Quality Control Manual — specifies the phantom tests, measurement methods, and numeric action limits for routine QC and the annual evaluation. 2
  • ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of MR Imaging Equipment — defines the scope and minimum frequency (at least annual) of the medical physicist's equipment performance evaluation. 3
  • ACR Practice Parameter for the Performance of Contrast-Enhanced MRI of the Breast — defines clinical indications, protocol elements, and interpretation expectations. 4
  • NEMA MS 1 and MS 3 — define standardized measurement methods for SNR and image uniformity that underpin the QC metrics. 5, 6

Facility accreditation and state facility-licensing bodies may impose additional requirements, but because MRI is non-ionizing, it generally falls outside a state's ionizing-radiation machine program. Across the states DRPS serves, a breast MRI program's binding quality requirements come from ACR accreditation and the facility's accreditation body rather than from a radiation-machine registration rule. Facilities should coordinate the breast MRI program with their broader accreditation support and medical physicist consulting efforts, and document the annual evaluation so it is defensible at survey. For the related program-level safety structure, see Building an MRI Safety Program.

Frequently Asked Questions (FAQs)

What does the ACR Breast MRI Accreditation Program actually review?

It reviews two linked image streams. Phantom images from the ACR MRI phantom demonstrate that the scanner meets geometric, uniformity, resolution, and stability criteria, and clinical images from real breast exams demonstrate that the protocol delivers thin slices, high in-plane resolution, uniform fat suppression, and a proper dynamic contrast-enhanced series. A qualified medical physicist's annual performance evaluation supports both.

Who is allowed to perform breast MRI quality control?

Routine QC such as weekly phantom scans and visual checklists is performed by a trained MRI technologist under an established program, while the annual MRI equipment performance evaluation must be performed or supervised by a qualified medical physicist or MRI scientist. The physicist reviews the technologist QC trend, repeats the quantitative measurements, and documents corrective action.

Why is fat suppression so important in breast MRI QC?

Breast tissue is largely fatty, and bright fat signal can both mimic and obscure enhancing lesions on dynamic contrast-enhanced images. Uniform, reproducible fat suppression across both breasts is therefore a core quality metric. Failed or asymmetric fat suppression is one of the most common reasons a breast MRI clinical image submission is deficient.

What are the key clinical image requirements for ACR breast MRI accreditation?

The clinical protocol must use thin contiguous slices (3 mm or less with no gap), high in-plane resolution (pixel dimension of about 1 mm or less), bilateral coverage, effective fat suppression, and a dynamic T1-weighted series with a pre-contrast acquisition followed by at least three post-contrast acquisitions completed within roughly the first several minutes after contrast injection.

How is MRI signal-to-noise ratio measured for QC?

SNR is measured on a uniform phantom using a NEMA-style method, most commonly the two-identical-image subtraction method. The mean signal is taken from a large region of interest in the phantom, and the noise is estimated from the standard deviation of the difference image divided by the square root of two. Tracking SNR over time catches coil degradation and RF chain problems before they affect clinical images.

How often does breast MRI equipment need a medical physicist evaluation?

A qualified medical physicist or MRI scientist must perform a comprehensive equipment performance evaluation at least annually, and also after major service or component replacement that could affect image quality. This evaluation is a requirement of ACR accreditation and of the ACR–AAPM technical standard for MRI performance monitoring.

Does breast MRI fall under MQSA like mammography?

No. MQSA governs mammography only. Breast MRI quality is governed by accreditation programs such as the ACR Breast MRI Accreditation Program and by facility accreditation bodies, not by the federal mammography statute. A facility should not assume its MQSA mammography compliance covers its breast MRI program.

Key Takeaways

  • Accreditation reviews two image streams. Phantom QC proves scanner stability; clinical images prove the protocol resolves and enhances small lesions.
  • SNR is the foundation metric. The NEMA two-image subtraction method quantifies it, and trending it catches coil and RF degradation early.
  • Uniformity and ghosting can mimic disease. Poor PIU or ghosting can imitate asymmetric enhancement between breasts, so both are core QC tests.
  • Fat suppression is diagnostic, not cosmetic. Asymmetric suppression hides or mimics cancer and is a frequent submission deficiency.
  • The dynamic series timing is sacred. Preserve the early post-contrast wash-in window; do not trade it away for resolution.
  • A qualified medical physicist evaluates annually. ACR accreditation and the ACR–AAPM technical standard require at least an annual equipment performance evaluation.

Conclusion

Breast MRI is unforgiving: the same scanner that passes a routine brain protocol can quietly fail to deliver diagnostic breast images if fat suppression is asymmetric, uniformity drifts, or the dynamic series timing slips. The ACR Breast MRI Accreditation Program addresses this by requiring both phantom and clinical evidence, backed by an annual medical physicist evaluation. 1, 2, 3

The practical takeaway for a breast MRI facility is to treat QC as a connected system rather than a set of isolated checks. When the technologist phantom log, the physicist evaluation, and the clinical fat-suppression review all live together and are trended over time, a deficient clinical submission can be traced to a measurable cause and corrected. A program run that way is not only more likely to pass accreditation; it is more likely to find the cancers breast MRI exists to find.

How DRPS Can Help

Diagnostic Radiation Physics Services supports breast MRI facilities with MRI physics testing, annual equipment performance evaluations, phantom QC program setup, fat-suppression and protocol review, and accreditation support aligned with the ACR Breast MRI Accreditation Program and the ACR–AAPM technical standard. Our board-certified physicists help facilities build QC programs that are documented, trended, and defensible at survey.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong breast MRI QC program makes the diagnostic-quality exam the routine exam, not the lucky one.

Related Resources

References

  1. American College of Radiology. Breast MRI Accreditation Program Requirements. American College of Radiology. acraccreditation.org
  2. American College of Radiology. ACR Magnetic Resonance Imaging Quality Control Manual. American College of Radiology. acr.org
  3. American College of Radiology. ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Magnetic Resonance Imaging (MRI) Equipment. acr.org
  4. American College of Radiology. ACR Practice Parameter for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. acr.org
  5. National Electrical Manufacturers Association. NEMA Standards Publication MS 1-2008 (R2014): Determination of Signal-to-Noise Ratio (SNR) in Diagnostic Magnetic Resonance Imaging. nema.org
  6. National Electrical Manufacturers Association. NEMA Standards Publication MS 3-2008 (R2014): Determination of Image Uniformity in Diagnostic Magnetic Resonance Images. nema.org
  7. Ren Z, Easley TO, Pineda FD, Guo X, Barber RF, Karczmar GS. Pharmacokinetic analysis of enhancement-constrained acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI. PLoS One. 2023;18(6):e0286123. doi:10.1371/journal.pone.0286123. PubMed
  8. El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011;197(6):1498-1505. doi:10.2214/AJR.10.4665. PubMed
  9. American College of Radiology. ACR BI-RADS Atlas: Breast Imaging Reporting and Data System — MRI. American College of Radiology. acr.org
  10. U.S. Food and Drug Administration. MRI (Magnetic Resonance Imaging) — Information for Industry and Benefits/Risks. fda.gov
  11. American College of Radiology. ACR Practice Parameter for Performing and Interpreting Magnetic Resonance Imaging (MRI). acr.org